ECIA (Encision) 5-Year Share Buyback Ratio : -0.60% (As of Mar. 2025)

View and export this data going back to 1996. Start your Free Trial

What is Encision 5-Year Share Buyback Ratio?

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

5-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past five years. It is calculated as the annualized percentage change in shares outstanding from five years ago to the current year. A positive ratio may indicate share buybacks over the period, while a zero or negative ratio may reflect no repurchases or potential share issuance. Encision's current 5-Year Share Buyback Ratio was -0.60%.

ECIA's 5-Year Share Buyback Ratio is ranked better than
76.34% of 655 companies
in the Medical Devices & Instruments industry
Industry Median: -3.8 vs ECIA: -0.60

Competitive Comparison of Encision's 5-Year Share Buyback Ratio

For the Medical Instruments & Supplies subindustry, Encision's 5-Year Share Buyback Ratio, along with its competitors' market caps and 5-Year Share Buyback Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Encision's 5-Year Share Buyback Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Encision's 5-Year Share Buyback Ratio distribution charts can be found below:

* The bar in red indicates where Encision's 5-Year Share Buyback Ratio falls into.

Save Embed

;

Save Embed

;

Encision 5-Year Share Buyback Ratio Calculation

This is the annualized percentage change in shares outstanding from five years ago to the current year. The annualized percentage change is calculated with least-square regression based on the latest six years of annual data on Shares Outstanding (EOP).

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

Encision (OTCPK:ECIA) 5-Year Share Buyback Ratio Explanation

A negative number means the company might be issuing new shares. A positive number indicates that the company is buying back shares.

Be Aware

Investors usually like share buybacks. But as pointed by Warren Buffett, only if a company buys back shares at the prices below the stock's intrinsic value, it rewards remaining shareholders. If a company buys its overvalued stocks back, it destroys shareholder value.

Encision 5-Year Share Buyback Ratio Related Terms

Thank you for viewing the detailed overview of Encision's 5-Year Share Buyback Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Encision Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Encision Inc (OTCPK:ECIA) » Definitions » 5-Year Share Buyback Ratio

Comparable Companies

Traded in Other Exchanges

N/A

Address

6797 Winchester Circle, Boulder, CO, USA, 80301

Website

https://www.encision.com

Encision Inc is a medical device company. The company develops and markets technology that provides unprecedented outcomes and patient safety in minimally invasive surgery. The company has established and developed AEM (Active Electrode Monitoring) technology and surgical instruments which provide surgeons with the desired tissue effects of cutting and coagulating tissue in laparoscopic procedures while preventing stray electrosurgical energy that can cause complications and even death. The segments of the company are Product and Service. Product designs develops, manufactures and markets patented surgical instruments. Service performs electrical engineering activities for external entities. Maximum revenue is generated from the product segment.

Executives

Robert H Fries	director	800 FILLMORE ST, DENVER CO 80206
Gregory J. Trudel	director, officer: CEO	5241 RIMROCK LANE, FORT COLLINS CO 80526
Peter D Geary	officer: VP of Operations	6797 WINCHESTER CIRCLE, BOULDER CO 80301
Jason E Johnson	officer: VP Sales	17752 WEDGEWOOD LANE, PRIOR LAKE MN 55372
Patrick R Dixon	director	6797 WINCHESTER CIRCLE, BOULDER CO 80301
Brian J Jackman	director	6797 WINCHESTER CIRCLE, SUITE 100, BOULDER CO 80301
Von Der Lippe Paul	director	6797 WINCHESTER CIRCLE, BOULDER CO 80301
Denise Baker	director	6797 WINCHESTER CIRCLE, BOULDER X1 80301
Vern D Kornelsen	director, 10 percent owner	4605 S. DENICE DR, ENGLEWOOD CO 80111
Partners Lllp Cmed	10 percent owner
Patrick W Pace	director	3701 SOARING EAGLE, AUSTIN TX 78746
Michael Biggs	officer: VP Engineering	6797 WINCHESTER CIRCLE, BOULDER CO 80301
Brad Greathouse	officer: VP RA/QA	6797 WINCHESTER CIRCLE, BOULDER CO 80301
Valerie Ray	officer: VP of Operations	6797 WINCHESTER CIRCLE, BOULDER CO 80301
David W Newton	director, officer: VP Technology	8099 NORTH 63RD STREET, LONGMONT CO 80503